News
Learn from a data scientist at Olink how to get the most out of your Olink® data. The following topics ...
Dr. Hu used the Olink® Explore platform to analyze proteins in the cerebrospinal fluid (CSF) of 315 HIV patients with ...
Dr. Galasko describes how Olink® PEA technology was employed to profile proteins related to mild cognitive impairment in HIV and ...
Multiple sclerosis (MS) is a chronic, heterogenous, progressive, and debilitating disease. The objective of Dr. Qureshi et al.’s research ...
Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteomics Platform
Press release: Strategic Partnership creates an end-to-end multi-omics platform for pharma, clinical research and biomarker discovery leveraging ...
Crohn’s disease (CD) is a heterogenous inflammatory bowel disease defined by a chronic inflammation of the gastrointestinal (GI) tract. ...
In this webinar, Dr. Grinspoon reviews a study in which HIV-infected patients with a hepatic fat fraction >5% were ...
In this video, Dr. deFilippi describes targeted discovery proteomics studies using various Olink® Target 96 panels to identify protein biomarkers ...
In this webinar, Klaus Pantel and Christoffer Gebhardt will discuss recent advances in liquid biopsy technology that allow researchers to ...
Welcome to the brand new Olink company website! Please let us know if you experience any problems.